Health Condition 1: E889- Metabolic disorder, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed patient of non alcoholic fatty liver or diagnose with Ultrasonography LFT For NAFLD Patients Adults aged 25 to 60 years BMI Greater than 25 overweight or obese Willingness to provide informed consent Lipid profile showing one or more abnormalities such as Total Cholesterol more than 200 LDL more than130 Triglycerides more than 150 HDL less than 40 male less than 50 female VLDL more than 30
Exclusion criteria
Exclusion criteria: Known liver disease viral hepatitis cirrhosis autoimmune hepatitis Diagnosed cases of Hepatitis B or C Cirrhosis or advanced liver fibrosis Autoimmune liver disease Pregnant or lactating women Individuals on hepatotoxic drugs eg steroids methotrexate Pregnant or lactating women Other chronic systemic illnesses Taking hepatotoxic medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At the end of the study it is expected that symptoms of Medovaha Srotodusti and changes in the lipid profile will help us understand NAFLD better This can also help in finding the disease early using both Ayurvedic and modern methodsTimepoint: AT BASELINE | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
PT KHUSHILAL SHARMA GOVERNMENT AUTONOMOUS AYURVEDA COLLEGE AND INSTITUTE BHOPAL